Michael Cyprys
Stock Analyst at Morgan Stanley
(4.07)
# 393
Out of 4,792 analysts
836
Total ratings
55.49%
Success rate
8.67%
Average return
Main Sectors:
Stocks Rated by Michael Cyprys
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
AMP Ameriprise Financial | Maintains: Equal-Weight | $507 → $542 | $455.81 | +18.91% | 6 | Mar 4, 2025 | |
RJF Raymond James Financial | Maintains: Equal-Weight | $149 → $161 | $130.28 | +23.58% | 3 | Mar 4, 2025 | |
TROW T. Rowe Price Group | Maintains: Equal-Weight | $126 → $121 | $86.22 | +40.34% | 56 | Feb 24, 2025 | |
HOOD Robinhood Markets | Maintains: Overweight | $64 → $90 | $38.26 | +135.23% | 17 | Feb 13, 2025 | |
APO Apollo Global Management | Maintains: Equal-Weight | $169 → $170 | $123.45 | +37.71% | 37 | Feb 11, 2025 | |
VRTS Virtus Investment Partners | Maintains: Underweight | $211 → $198 | $161.76 | +22.40% | 56 | Feb 6, 2025 | |
VIRT Virtu Financial | Maintains: Equal-Weight | $31 → $33 | $37.40 | -11.76% | 25 | Feb 6, 2025 | |
LPLA LPL Financial Holdings | Maintains: Overweight | $379 → $413 | $312.75 | +32.05% | 48 | Feb 6, 2025 | |
KKR KKR & Co. | Maintains: Equal-Weight | $157 → $156 | $102.55 | +52.12% | 39 | Feb 6, 2025 | |
IVZ Invesco | Maintains: Equal-Weight | $18 → $19 | $13.83 | +37.38% | 46 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $84 → $91 | $74.87 | +21.54% | 48 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $50.35 | +58.89% | 1 | Jan 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $64 → $66 | $54.89 | +20.24% | 37 | Dec 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $18 → $19 | $17.95 | +5.85% | 17 | Dec 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $60 → $65 | $47.72 | +36.21% | 24 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $182 → $190 | $140.89 | +34.86% | 37 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $10.53 | +23.46% | 12 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $199 | $225.80 | -11.87% | 4 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $93 | $73.79 | +26.03% | 28 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $262 → $314 | $216.15 | +45.27% | 34 | Oct 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $160 → $174 | $167.56 | +3.84% | 21 | Oct 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $73 | $42.33 | +72.45% | 15 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $46 → $50 | $38.71 | +29.17% | 35 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $11 → $14 | $8.73 | +60.37% | 10 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $164 → $177 | $133.10 | +32.98% | 47 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $136 → $162 | $130.59 | +24.05% | 25 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7.75 → $9.25 | $8.53 | +8.44% | 8 | Apr 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $122 → $125 | $149.02 | -16.12% | 21 | Apr 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $196 → $201 | $268.36 | -25.10% | 13 | Feb 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $785 → $828 | $887.65 | -6.72% | 36 | Jan 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $40 → $43 | $23.01 | +86.88% | 1 | Nov 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $239 → $248 | $530.16 | -53.22% | 8 | Jan 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $38 → $41 | $1.04 | +3,842.31% | 21 | Oct 6, 2020 |
Ameriprise Financial
Mar 4, 2025
Maintains: Equal-Weight
Price Target: $507 → $542
Current: $455.81
Upside: +18.91%
Raymond James Financial
Mar 4, 2025
Maintains: Equal-Weight
Price Target: $149 → $161
Current: $130.28
Upside: +23.58%
T. Rowe Price Group
Feb 24, 2025
Maintains: Equal-Weight
Price Target: $126 → $121
Current: $86.22
Upside: +40.34%
Robinhood Markets
Feb 13, 2025
Maintains: Overweight
Price Target: $64 → $90
Current: $38.26
Upside: +135.23%
Apollo Global Management
Feb 11, 2025
Maintains: Equal-Weight
Price Target: $169 → $170
Current: $123.45
Upside: +37.71%
Virtus Investment Partners
Feb 6, 2025
Maintains: Underweight
Price Target: $211 → $198
Current: $161.76
Upside: +22.40%
Virtu Financial
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $31 → $33
Current: $37.40
Upside: -11.76%
LPL Financial Holdings
Feb 6, 2025
Maintains: Overweight
Price Target: $379 → $413
Current: $312.75
Upside: +32.05%
KKR & Co.
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $156
Current: $102.55
Upside: +52.12%
Invesco
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $18 → $19
Current: $13.83
Upside: +37.38%
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $84 → $91
Current: $74.87
Upside: +21.54%
Jan 23, 2025
Initiates: Overweight
Price Target: $80
Current: $50.35
Upside: +58.89%
Dec 20, 2024
Maintains: Equal-Weight
Price Target: $64 → $66
Current: $54.89
Upside: +20.24%
Dec 20, 2024
Maintains: Underweight
Price Target: $18 → $19
Current: $17.95
Upside: +5.85%
Nov 14, 2024
Maintains: Equal-Weight
Price Target: $60 → $65
Current: $47.72
Upside: +36.21%
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $182 → $190
Current: $140.89
Upside: +34.86%
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $10.53
Upside: +23.46%
Nov 6, 2024
Downgrades: Underweight
Price Target: $199
Current: $225.80
Upside: -11.87%
Oct 25, 2024
Maintains: Overweight
Price Target: $92 → $93
Current: $73.79
Upside: +26.03%
Oct 17, 2024
Maintains: Equal-Weight
Price Target: $262 → $314
Current: $216.15
Upside: +45.27%
Oct 17, 2024
Maintains: Equal-Weight
Price Target: $160 → $174
Current: $167.56
Upside: +3.84%
Oct 10, 2024
Maintains: Overweight
Price Target: $55 → $73
Current: $42.33
Upside: +72.45%
Oct 10, 2024
Maintains: Equal-Weight
Price Target: $46 → $50
Current: $38.71
Upside: +29.17%
Oct 10, 2024
Maintains: Overweight
Price Target: $11 → $14
Current: $8.73
Upside: +60.37%
Oct 10, 2024
Maintains: Overweight
Price Target: $164 → $177
Current: $133.10
Upside: +32.98%
Oct 10, 2024
Maintains: Equal-Weight
Price Target: $136 → $162
Current: $130.59
Upside: +24.05%
Apr 17, 2024
Maintains: Equal-Weight
Price Target: $7.75 → $9.25
Current: $8.53
Upside: +8.44%
Apr 9, 2024
Maintains: Overweight
Price Target: $122 → $125
Current: $149.02
Upside: -16.12%
Feb 13, 2023
Maintains: Equal-Weight
Price Target: $196 → $201
Current: $268.36
Upside: -25.10%
Jan 17, 2023
Maintains: Overweight
Price Target: $785 → $828
Current: $887.65
Upside: -6.72%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $40 → $43
Current: $23.01
Upside: +86.88%
Jan 12, 2021
Maintains: Equal-Weight
Price Target: $239 → $248
Current: $530.16
Upside: -53.22%
Oct 6, 2020
Maintains: Equal-Weight
Price Target: $38 → $41
Current: $1.04
Upside: +3,842.31%